Skip to content

ORGO - Organogenesis Holdings Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchO

Organogenesis Holdings Inc

ORGO · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

O

ORGOOrganogenesis Holdings Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $7.08
52-wk low: $1.54
Prev close: $4.41
Mkt cap: $245.8M
Fwd P/E: 12.7x
Beta: 1.32

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$44.1M

AQ
AQR
Q2 2026 13F
$7.3M
position
DS
D.E. Shaw
Q2 2026 13F

Earnings

Reported Aug 6, 2026

Earnings came in 102.9% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -18.4%
Forward P/E: 12.67
Market cap: $246M

Valuation

P/S0.54
P/B1.55

Quality

Operating margin-119.3%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ORGO
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Market cap: $245.77M
Beta: 1.32

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

0.5x

P/B

1.5x

Profit margin

-18.4%

Op margin

-119.3%

ROE

-25.9%

$7.0M

position

MI

Millennium

Israel Englander · Q4 2025 13F

$2.5M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for ORGO

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.71-102.9%

-$0.35 expected

Next report

What the street expects next

ROE

-25.9%

ROA-4.1%

Growth

Beta1.32